1 |
Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept) |
Abatacept |
5件: D00742 D00742, D02597 D02597, D02598 D02598, D03203 D03203, D04358 D04358 💬 |
CD80 4件: CD80, CD86, LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
2 |
Toz |
- |
- |
- |
- |
006 1件: 6 💬 |
3 |
Tozadenant |
Tozadenant |
1件: D10174 D10174 💬 |
ADORA2A 1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 1件: 6 💬 |
4 |
Tozadenant (syn115) 120 mg bid |
Tozadenant |
1件: D10174 D10174 💬 |
ADORA2A 1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 1件: 6 💬 |
5 |
Tozadenant (syn115) 180 mg bid |
Tozadenant |
1件: D10174 D10174 💬 |
ADORA2A 1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 1件: 6 💬 |
6 |
Tozadenant (syn115) 240 mg bid |
Tozadenant |
1件: D10174 D10174 💬 |
ADORA2A 1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 1件: 6 💬 |
7 |
Tozadenant (syn115) 60 mg bid |
Tozadenant |
1件: D10174 D10174 💬 |
ADORA2A 1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 1件: 6 💬 |